Primary liver cancer;Tumeurs primitives hépatiques

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Quivrin, M ^a   Mornex, F ^b   Enachescu, C ^b   Martin, E ^a   Ligey Bartolomeu, A ^a   Nouhaud, E ^a   Chamois, J ^a   Maingon, P ^a   Crehange G ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Atlas; Conformal radiotherapy; Hepatocarcinoma; Target volumes

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER SURGERY; EXTERNAL BEAM RADIOTHERAPY; HIGH RISK PATIENT; HUMAN; LIVER CANCER; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STANDARD; STEREOTACTIC TREATMENT; TUMOR LOCALIZATION;

COMBINED MODALITY THERAPY; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, CONFORMAL;

EID: 78649765413     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70013-5     Document Type: Article

References (25)

1. Beddar A.S., Kainz K., Briere T.M., Tsunashima Y., Pan T., Prado K., et al. Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT. Int J Radiat Oncol Biol Phys 2007, 67:630-638.
2. Borgelt B.B., Gelber R., Brady L.W., Griffin T., Hendrickson F.R. The palliation of hepatic metastases: Results of the radiation therapy oncology group pilot study. Int J Radiat Oncol Biol Phys 1981, 7:587-591.
3. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
4. Cheng J.C., Wu J.K., Lee P.C., Liu H.S., Jian J.J., Lin Y.M., et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2004, 60:1502-1509.
5. Dawson L.A., Eccles C., Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006, 45:856-864.
6. Dawson L.A., Normolle D., Balter J.M., McGinn C.J., Lawrence T.S., Ten Haken R.K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002, 53:810-821.
7. Dawson L.A. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 2008, 12:96-101.
8. Dilou N., Patouillard B., Audigier J.C. Les classifications de prédiction de survie du carcinome hépatocellulaire. Gastroenterol Clin Biol 2004, 28:359-366.
9. Eccles C.L., Bissonnette J.P., Craig T., Taremi M., Wu X., Dawson L.A. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies. Int J Radiat Oncol Biol Phys 2008, 72:582-588.
10. Ganne-Carrié N., Mohand D., N'Kontchou G., Grando-Lemaire V., Trinchet J.C. Diagnostic et traitement du carcinome hépatocellulaire chez les malades atteints de cirrhose. Gastroenterol Clin Biol 2002, 26:73-77.
11. Guide des procédures de radiothérapie externe 2007 - SFRO. Cancer Radiother 2008;12:141-314.
12. Krishnan S., Dawson L.A., Seong J., Akine Y., Beddar S., Briere T.M., et al. Radiotherapy for hepatocellular carcinoma: an overview. Ann Surg Oncol 2008, 15:1015-1024.
13. McGinn C.J., Ten Haken R.K., Ensminger W.D., Walker S., Wang S., Lawrence T.S. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998, 16:2246-2252.
14. Liang S.X., Zhu X.D., Xu Z.Y., Zhu J., Zhao J.D., Lu H.J., et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 2006, 65:426-434.
15. Mornex F., Girard N., Beziat C., Kubas A., Khodri M., Trepo C., et al. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006, 66:1152-1158.
16. Park W., Lim D.H., Paik S.W., Koh K.C., Choi M.S., Park C.K., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005, 61:1143-1150.
17. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer Journal for Clinicians 2005, 55:74-108.
18. Russell A.H., Clyde C., Wasserman T.H., Turner S.S., Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the rtog dose escalating protocol. Int J Radiat Oncol Biol Phys 1993, 27:117-123.
19. Seong J., Shim S.J., Lee I.J., Han K.H., Chon C.Y., Ahn S.H. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1037-1042.
20. Seong J., Park H.C., Han K.H., Chon C.Y. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003, 55:329-336.
21. Talwalkar J.A., Gores G.J. Diagnosis and staging of hepatocellular carcinoma. Gastroenterol 2004, 127:S126-S132.
22. UICC International Union Against Cancer: TNM Classification of Malignant Disease. 2002, 6th ed. New York.
23. Wagman R., Yorke E., Ford E., Giraud P., Mageras G., Minsky B., et al. Respiratory gating for liver tumors: use in dose escalation. Int J Radiat Oncol Biol Phys 2003, 55:659-668.
24. Wei-Jian Guo, Er-Xin Yu, Lu-Ming Liu, Jie Li, Zhen Chen, Jun-Hua Lin, et al. Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 2003, 9:1697-1701.
25. Xi M., Liu M.Z., Deng X.W., Zhang L., Huang X.Y., Liu H., et al. Defining internal target volume (ITV) for hepatocellular carcinoma using four dimensional CT. Radioth Oncol 2007, 84:272-278.